Unlocking the undruggable spliceosome: generative AI and structural dynamics in cancer therapy

Area of Science:

• Molecular biology
• Cancer research
• Structural biology
• Computational chemistry

Background:

• The spliceosome is crucial for generating diverse RNA molecules, but its complexity presents vulnerabilities exploitable in cancer.
• Mutations in spliceosome components like SF3B1, U2AF1, and SRSF2 alter splice-site recognition, driving cancer development and creating unique molecular signatures.
• These spliceosome alterations serve as potential diagnostic and prognostic biomarkers, but therapeutic strategies remain challenging.

Purpose of the Study:

• To review the necessity of dynamic structural insights into the spliceosome beyond static snapshots for therapeutic development.
• To explore the integration of advanced computational methods with artificial intelligence for understanding spliceosome dynamics.
• To evaluate next-generation therapeutic strategies targeting spliceosome defects for cancer treatment and immunotherapy.

Main Methods:

• Utilizing physics-based molecular simulations and enhanced sampling techniques to study dynamic structural ensembles of the spliceosome.
• Integrating generative Artificial Intelligence to identify spliceosome intermediate states, allosteric pockets, and intrinsically disordered regions.
• Evaluating novel therapeutic approaches including biomarkers, allosteric modulators, and synthetic lethality strategies.

Main Results:

• The review highlights the potential of dynamic structural analysis to reveal previously uncharacterized spliceosome states and functional mechanisms.
• Computational and AI-driven methods can map cryptic allosteric sites and intrinsically disordered regions, offering new therapeutic targets.
• Understanding spliceosome dynamics can guide the development of novel biomarkers and targeted therapies, including splicing-derived neoantigens for immunotherapy.

Conclusions:

• A shift towards dynamic structural ensembles, enabled by advanced simulations and AI, is crucial for unlocking the therapeutic potential of targeting the spliceosome in cancer.
• Deciphering altered spliceosome dynamics provides a roadmap for developing precision therapies, including novel biomarkers and immunotherapies.
• This approach promises to translate mechanistic insights into effective clinical strategies for cancer treatment.